Skip to main content
  • Displaying 30 - 40 of 55
  • First
  • «
  • 2
  • 3
  • 4
  • 5
  • 6
  • »
  • Last
Malaria surveillance and measuring the impact of interventions, examples from Uganda
Moses Kamya, MBChB, MMed, MPH, PhD, Makerere University School of Medicine
Tags: SciTalk Infectious Disease Pre Meeting Workshop Malaria education ePrimer public health

Recorded on February 19, 2017

Pre Meeting Workshop

Malaria: From Innovation to Eradication

Feb 19 - Feb 23, 2017 | Kampala, Uganda

The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.

This Keystone Symposia SciTalk was made possible by a grant from the

bca788e6e9d3a5c4441b5d7e48c84f22.png

HIV Vaccines: Path to Efficacy
Moderator: Gabriella Scarlatti, MD, PhD, Global HIV Vaccine Enterprise    |     Panelist: Dr. Barton F. Haynes, MD, Professor of Medicine    |     Panelist: Penny Moore, PhD    |     Panelist: Nicole Frahm, PhD
Tags: ePanel HIV Infectious Disease education vaccines infectious disease epanels

Keystone Symposia ePanel:

HIV Vaccines: Path to Efficacy

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

053719e550b3ca307ef660d0cb63cd9b.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

Structural Studies of HIV-1 Infection
Pamela J. Bjorkman, PhD, California Institute of Technology
Tags: HIV SciTalk Infectious Disease

Keystone Symposia SciTalks:

Structural Studies of HIV-1 Infection

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

af1bb87294c52d22f7d29d6250f4d807.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

Importance of CD8 T Cell Responses Targeting Variable Epitopes in SIV
Matthew Sutton, University of Wisconsin-Madison
Tags: HIV SciTalk Infectious Disease immunology

Keystone Symposia SciTalks:

Importance of CD8 T Cell Responses Targeting Variable Epitopes in SIV


Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA



b7b9d6408435e392dd9b4f068345ca9b.png


___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

AAV-expressed eCD4-lg as an HIV-1 vaccine alternative
Michael Farzan, PhD, The Scripps Research Institute
Tags: HIV SciTalk Infectious Disease protein vaccines

Keystone Symposia SciTalks:

AAV-expressed eCD4-lg as an HIV-1 vaccine alternative

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

64990022d08664af75b81a390364b4d2.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

Novel Therapeutic Interventions in the Targeting of the HIV Cell Reservoir
Giuseppe Pantaleo, MD, Lausanne University Hospital
Tags: HIV SciTalk Infectious Disease drug discovery

Keystone Symposia SciTalks:

Novel Therapeutic Interventions in the Targeting of the HIV Cell Reservoir

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

6e1f50054c45e71477ec93c944581c05.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

A Broadly Neutralizing Antibody from an Elite Neutralizer Target a Novel Site at the gp120-gp41 Interface
Marit J. van Gils, PhD, Academic Medical Center, University of Amsterdam, the Netherlands
Tags: HIV SciTalk Infectious Disease protein immunology

Keystone Symposia SciTalks:

A Broadly Neutralizing Antibody from an Elite Neutralizer Target a Novel Site at the gp120-gp41 Interface

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

6ef56760d499adacb689a3e86fee0619.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

Profiling protective antibody responses
Dr. Margaret E. Ackerman, PhD, Principal Investigator , Thayer School of Engineering at Dartmouth College
Tags: HIV SciTalk Infectious Disease immunology

Keystone Symposia SciTalks:

Profiling protective antibody responses

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

e5ec7f3e080f77d9bd28d5fb72f40c41.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

HIV Vaccine Humoral Immunity, Immune Correlates and Mechanistic Insights.
Georgia Tomaras, PhD, Duke Human Vaccine Institute,
Tags: HIV SciTalk Infectious Disease vaccines

Keystone Symposia SciTalks:

Vaccine Humoral Immunity, Immune Correlates and Mechanistic Insights

Recorded: March 20 - 24, 2016

Keystone Symposia meeting: HIV Vaccines [X8]

Location: Resort at Squaw Creek, Olympic Valley, CA

d0383f6fd7afe65156a3c02a785d41fc.png

___


About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

From Neuroscience to Therapy — How Do We Get There?
Moderator: Steven E. Hyman, MD, Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT    |     Panelist: Benjamin Neale, PhD, Massachusetts General Hospital    |     Panelist: Guoping Feng, PhD, McGovern Institute for Brain Research    |     Panelist: Stacie Weninger, PhD, F-Prime Biomedical Research Initiative
Tags: ePanel Neuroscience drug discovery neurobiology neurobiology epanels

Keystone Symposia LivePanel:

From Neuroscience to Therapy — How Do We Get There?

Originally broadcast live on February 11, 2016, this spirited 90-minute discussion involved four industry thought leaders discussing the state of the field and the path forward. Discussion topics focused on:

  • Basic nature of disease and how it poses a challenge
  • GWAS studies
  • How to do studies correctly, moving from failure to success
  • How to identify, prioritize and validate targets

43105b679e6a9f0b29c5c62e6a03ca6b.png

___

About Keystone Symposia:

Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.

Website: www.keystonesymposia.org

  • Displaying 30 - 40 of 55
  • First
  • «
  • 2
  • 3
  • 4
  • 5
  • 6
  • »
  • Last